How much is Biobeat worth in 2026?

Biobeat has a current valuation of $102.7M based on their Later Stage VC round and secondary market data.

How much funding has Biobeat raised?

Biobeat has raised $21.8M in total funding across 0 funding rounds.

Biobeat

Website

Biobeat valuation and funding history | Last updated: May 6, 2024

Current Valuation

$102.7M

As of May 6, 2024

Total Funding Raised

$21.8M

Last Round

Later Stage VC

$10.8M

Last Funding

May 2024

Funding date

Capital Efficiency

4.71x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Biobeat is currently valued at $102.7M as of May 6, 2024. The company has raised a total of $21.8M in funding.

Capital Efficiency

With a capital efficiency ratio of 4.71x, Biobeat has achieved a valuation that is 4.71 times the total capital raised.

Track Biobeat Valuation Updates

Get notified when Biobeat raises new funding or valuation changes

Explore More Data

Detailed analysis for Biobeat

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Biobeat's valuation history, funding rounds, and growth metrics.

No credit card required

What is Biobeat Worth in 2026?

Biobeat is a leading private company in the technology sector. Track Biobeat's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Biobeat Valuation is Determined

Private company valuations like Biobeat's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.